Henry Rodriguez
PhD
Director, Office of Cancer Clinical Proteomics Research
👥Biography 个人简介
Henry Rodriguez has directed the NCI Clinical Proteomic Tumor Analysis Consortium from its inception, building the infrastructure and scientific community that has produced landmark proteogenomic characterizations of over 15 cancer types. His leadership in proteomics assay standardization and quality control has enabled multi-laboratory reproducibility essential for clinical translation. His vision for integrating proteomics into precision oncology has established the CPTAC program as the definitive resource for cancer proteogenomic data.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Henry Rodriguez 的研究动态
Follow Henry Rodriguez's research updates
留下邮箱，当我们发布与 Henry Rodriguez（National Cancer Institute）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment